ASX CODE: TLX

Telix Pharmaceuticals ASX TLX phase two prostate cancer imaging study GenesisCare

Telix Pharmaceuticals to begin phase two prostate cancer imaging study

Biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) has been given the green light to commence a phase two study involving its medical imaging technology on...
Read more
Telix Pharmaceuticals ASX TLX prostate cancer imaging technology

Telix Pharmaceuticals partners with Mexican nuclear science firm to advance prostate imaging technology

Australian biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) has completed an in-licensing agremeent with Mexico’s Instituto Nacional de Investigaciones Nucleares (ININ) for a clinical-stage radiopharmaceutical...
Read more
Telix Pharmaceuticals ASX TLX Advanced Nuclear Medicine Ingredients

Telix Pharmaceuticals acquires Belgium-based Advanced Nuclear Medicine Ingredients

Telix Pharmaceuticals (ASX: TLX) has made a play for Belgium company Advanced Nuclear Medicine Ingredients, with the takeover valuing ANMI at over £5.15 million...
Read more
Telix Pharmaceuticals ASX TLX phase 3 trial recruitment renal cell carcinoma RCC zirconium imaging oncology ZIRCON Australia

Telix Pharmaceuticals readies recruitment for phase 3 trial in renal cancer

Melbourne-based biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) is preparing to commence recruitment for its zirconium imaging in renal cancer oncology (ZIRCON) phase 3 trial...
Read more
Telix Pharmaceuticals ASX TSX cancer treatment GenesisCare

Telix Pharmaceuticals strikes cancer treatment access deal with GenesisCare

Biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) has teamed up with the largest private provider of oncology services in Australia and Europe, GenesisCare, to accelerate...
Read more

RECENT POSTS

STOCK SUMMARY

INVESTOR TOOLS

HOT TOPICS

TRENDING POSTS

Small Caps ASX Australian stock market
Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
Copyright 2019 Small Caps. All rights reserved.